Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #12,421 to #12,470.
- Cynosumab (1 revision)
- Cyphenothrin (1 revision)
- Cyprazepam (1 revision)
- Cyprenorphine (1 revision)
- Cypress Spurge (1 revision)
- Cypripedium pubescens (1 revision)
- Cys-loop receptors (1 revision)
- Cystathionine-beta-synthase (1 revision)
- Cysteamine (topical) (1 revision)
- Cysteine dioxygenase type 1 (1 revision)
- Cysteine rich protein 3 (1 revision)
- Cysteine rich secretory protein lccl domain containing 1 (1 revision)
- Cysteine sulfinic acid (1 revision)
- Cystercosis (1 revision)
- Cystic Fibrosis Foundation (1 revision)
- Cystic acne (1 revision)
- Cystic duct (1 revision)
- Cystic fibrosis natural history (1 revision)
- Cystic nephroma (patient information) (1 revision)
- Cystica profunda (1 revision)
- Cysticercosis natural history (1 revision)
- Cysticerocosis (1 revision)
- Cystine (1 revision)
- Cystitis natural history (1 revision)
- Cystovirus (1 revision)
- Cytochemistry (1 revision)
- Cytochrome b5, type A (1 revision)
- Cytokines and their receptors (1 revision)
- Cytokinin (1 revision)
- Cytoluminescent therapy (1 revision)
- Cytome (1 revision)
- Cytomegalovirus Immune Globulin Intravenous Injection (patient information) (1 revision)
- Cytomegalovirus infection natural history (1 revision)
- Cytomics (1 revision)
- Cytopathology (1 revision)
- Cytopathy (1 revision)
- Cytopenia (1 revision)
- Cytoplasm (1 revision)
- Cytoplasmic polyadenylation element (1 revision)
- Cytosine arabinose syndrome (1 revision)
- Cytoskeleton associated protein 2 like (1 revision)
- Cytosol (1 revision)
- Cytotoxicity (1 revision)
- Cytoxan Lyophilized (1 revision)
- Cytrel (1 revision)
- D (1 revision)
- D-Galacturonic acid (1 revision)
- D-Lysergic acid N-(α-hydroxyethyl)amide (1 revision)
- D-block contraction (1 revision)
- DAAM1 (1 revision)